请后下载此文档！
听力学及言语疾病杂志JOURNAL OF AUDIOLOGY AND SPEECH PATHOLOGY
2003 Vol.11 No.4 P.303-305
感音神经性聋分子生物学研究进展
罗伟
孙建军
文章编号：1006-7299(2003)04-0303-03
感音神经性聋(sensorineural hearing loss,SNHL)的发病机制目前尚未完全阐明,其致病因素和临床表现形式的多样性使得治疗上难以获得确切有效的结果.近年来,有遗传学证据表明感音神经性聋的发生与染色体异常有关,先天性或后天性聋可由一些特定基因的突变导致[1-4].……
作者单位：罗伟（解放军四一四医院耳鼻咽喉科 南京 210015）
孙建军（海军总医院全军耳鼻咽喉科中心）
参考文献：
［1］Hmani M, Ghorbel A, Boulila Elgaied A, et al. A novel locus for Usher syndrome type Ⅱ, USH2B,maps to chromosome 3 at p23- 24.2[J].Eur J Hum Genet, 1999,7:363.
［2］Gasparini P, Estivill X, Fortina P. Vestibular and hearing loss in genetic and metabolic disorder[ J]. Curr Opin Neurol, 1999,12:35.
［3］Kubisch C, Schroeder BC, Friedrich T, et al. KCNQ4, anovel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness[ J]. Cell, 1999,96: 437.
［4］Hasson T, Heintzelman MB, Santos Sacchi J, et al. Expression in cochlear and retino of myosin Ⅶa, the gene product defective in Usher syndrome type IB[J] .Proc Natl Acad Sci USA, 1995,92:9 815.
［5］Masmoudi S, Charfedine I, Hmani M,et al. Pendred syndrome:phenotypic variability in two families carrying the same PDS missense mutation[J] .Am J Med Genet,2000,90:38.
［6］Yajima I, Sato S, Kimura T, et al. An L1 element intronic insertion in the black - eyed white (Miff[mi - bw] ) gene: the loss of a single Miff isoform responsible for the defect and inner ear deafness [ J ]. Hum Mol Genet, 1999,8:1 431.
［7］Fukushima K, Kasai N, Ueki Y, et al. A gene for fluctuating, progressive autosomal dominant nonsyndromic hearing loss, DFNA16, maps to chromosome 2q23-24.3[J] .Am J Hum Genet,1999,65:141.
［8］Seidman MD. Effects of dietary restricition and antioxidiants on presbyacusis[ J]. Laryngoscope, 2000, 110:727.
［9］Seidman MD, Khan MJ, Bai U, et al. Biologic activity of mitochondrial metabolities on aging and age - related hearing loss[J]. Am J Otol,2000,21:161.
［10］Yamasoba T, Schacht J, Shoji F, et al. Attenuation of cochlear damage from noise traurma by an iron chelator, a free radical scavenger and glial cell line- derived neurotrophic factor in vivo[J]. Brain Res, 1999,815:317.
［11］Johnson DF, Prezant TR, Lubavin B, et al. Isolation of overexpressed yeast genes which prevents aminoglycoside toxicity [J]. Hear Res,1998,120:62.
［12］Estivill X, Govea N, Barcelo E, et al. Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment of aminoglycosides[ J]. Am J Hum Genet, 1998,62:27.
［13］Hutchin T. Sensorineural hearing loss and the 1555G mitochondrial DNA mutation[J]. Acta Otolaryngol, 1999,119:48.
［14］Casano RA,Johnson DF, Bykhovskaya Y,et al. Inherit susceptibility to aminoglycoside ototoxicity: genetic heterogeneity and clinic implications[J]. Am J Otolaryngol, 1999,20:151.
［15］Ensink RJ, Verhoeven K, Marres HA, et al. Early onset sensorineural hearing loss and late onset neurological compliants caused by a mitochondrial mutation at position 7 472[J]. Arch Otolaryngol Head Neck Surg, 1998,124:886.
［16］Skvorak Giersch AB, Morton CC. Genetic cause of nonsyndromic hearing loss[J]. Curr Opin Pediatr, 1999,11:551.
［17］Gill H, Michaels L, Phelps PD, et al. Histopathological findings suggest the diagnoise in an atypical case of Pendred syndrome[J]. Clin Otolaryngol, 1999,24:523.
［18］Eudy JD, Weston MD, Yan S, et al. Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type Ⅱ a[J].Science, 1998,280:175.